MAR · Marriott International Inc /Md/ · Insider Trading

The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.

The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Shares transferred as a capital distribution to Mr. J.W. Marriott, Jr. in a transaction exempt as to the transferee under Rule 16a-13. JWM Family Enterprises, Inc. did not receive any consideration in exchange for this capital distribution.

The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.

Shares transferred as a capital distribution to Mr. J.W. Marriott, Jr. in a transaction exempt as to the transferee under Rule 16a-13. JWM Family Enterprises, Inc. did not receive any consideration in exchange for this capital distribution.

The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.

Shares transferred as a capital distribution to Mr. J.W. Marriott, Jr. in a transaction exempt as to the transferee under Rule 16a-13. JWM Family Enterprises, Inc. did not receive any consideration in exchange for this capital distribution.

The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Shares transferred as a capital distribution to Mr. J.W. Marriott, Jr. in a transaction exempt as to the transferee under Rule 16a-13. JWM Family Enterprises, Inc. did not receive any consideration in exchange for this capital distribution.

The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.

Shares withheld by the Company to cover taxes associated with vesting of RSUs.

Quarterly director fees deferred pursuant to the Company stock plan. The shares are fully vested and will be distributed following termination of service as a Board member.

Quarterly director fees deferred pursuant to the Company stock plan. The shares are fully vested and will be distributed following termination of service as a Board member.

On May 12, 2026, the Reporting Person reported that 2,340 shares were gifted on May 8, 2026. 52 shares included within these 2,340 shares were not processed at that time due to an inadvertent oversight. The 52 shares were processed on May 18, 2026, and the Reporting Person is filing this Form 4 to reflect that transaction.

On May 12, 2026, the Reporting Person reported the receipt of 936 shares that were gifted on May 8, 2026. 52 shares included within these 936 shares were not processed at that time due to an inadvertent oversight. The 52 shares were processed on May 18, 2026, and the Reporting Person is filing this Form 4 to reflect that transaction.

The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.

Represents the weighted average sale price. The highest price at which shares were sold was $361.68 and the lowest price at which shares were sold was $361.48.

The shares will vest on a daily pro rata basis over the 12-month period following the grant and will be distributed on the one-year anniversary of the grant.

The shares will vest on a daily pro rata basis over the 12-month period following the grant and will be distributed on the one-year anniversary of the grant.

The shares will vest on a daily pro-rata basis over the twelve (12) month period following the grant and be distributed following termination of service as a Board member.

The shares will vest on a daily pro-rata basis over the twelve (12) month period following the grant and be distributed following termination of service as a Board member.

The shares will vest on a daily pro-rata basis over the twelve (12) month period following the grant and be distributed following termination of service as a Board member.

The shares will vest on a daily pro-rata basis over the twelve (12) month period following the grant and be distributed following termination of service as a Board member.

The RSUs will vest on February 15, 2029.

The RSUs will vest on February 15, 2029.

The shares will vest on a daily pro-rata basis over the twelve (12) month period following the grant and be distributed following termination of service as a Board member.

The shares will vest on a daily pro-rata basis over the twelve (12) month period following the grant and be distributed following termination of service as a Board member.

The shares will vest on a daily pro-rata basis over the twelve (12) month period following the grant and be distributed in four annual installments following termination of service as a Board member.

The shares will vest on a daily pro-rata basis over the twelve (12) month period following the grant and be distributed following termination of service as a Board member.

Board retainer fee received in the form of SARs. The SARs are fully vested and will be exercisable on the last business day immediately preceding the next annual meeting of stockholders.

The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.

The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.

The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Quarterly director fees deferred pursuant to the Company stock plan. The shares are fully vested and will be distributed following termination of service as a Board member.

Shares withheld by the Company to cover taxes associated with vesting of RSUs.

Stock Appreciation Rights granted on 2/16/2023 that vest in three equal installments beginning on February 15, 2024 and thereafter on the anniversary of that date.

The Reporting Person received a net of 2,504 shares of common stock upon the exercise of 4,992 Stock Appreciation Rights ("SARs"). A total of 2,488 shares of common stock underlying such SARs were withheld in payment of the exercise price.

The Reporting Person received a net of 238 shares of common stock upon the exercise of 1,240 Stock Appreciation Rights ("SARs"). A total of 1,002 shares of common stock underlying such SARs were withheld in payment of the exercise price.

The Reporting Person received a net of 750 shares of common stock upon the exercise of 2,298 Stock Appreciation Rights ("SARs"). A total of 1,548 shares of common stock underlying such SARs were withheld in payment of the exercise price.

Stock Appreciation Rights granted on 2/14/2025 that vest in three equal installments beginning on February 15, 2026 and thereafter on the anniversary of that date.

Stock Appreciation Rights granted on 2/15/2024 that vest in three equal installments beginning on February 15, 2025 and thereafter on the anniversary of that date.

Represents the weighted average sale price. The highest price at which shares were sold was $358.5400 and the lowest price at which shares were sold was $358.2300.

Shares withheld by the Company to cover taxes associated with vesting of RSUs.